Pharma sector must move from cost competitiveness to innovation: Experts ...Middle East

India's pharmaceutical industry needs to move beyond its traditional strength in cost-effective generic medicines and focus on innovation, advanced manufacturing, quality and global regulatory standards to realise its growth potential, industry experts said. With India targeting a pharmaceutical market of USD 130 billion by 2030, experts at a recent industry event in Hyderabad said the next phase of growth would require greater investments in research and development, digital technologies and contract research and development manufacturing. The discussions were held ahead of the 19th edition of CPHI & PMEC India 2026, scheduled to be held in November across venues in Delhi-NCR. The official launch and precursor event of CPHI & PMEC India 2026, held under the banner of the Pharma Leadership Exchange, brought together pharma leaders, CXOs, industry stalwarts, and key voices from across India's pharmaceutical and life sciences ecosystem. Sarvesh Singh, CEO, Lifesciences and ...

Hence then, the article about pharma sector must move from cost competitiveness to innovation experts was published today ( Tuesday 18/08/2026 - 09:08 AM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Pharma sector must move from cost competitiveness to innovation: Experts )

Also on site :

• FIGHT FOR CONTROL OF PROFITABLE WEST VIRGINIA POWER PLANT ESCALATES WITH MOTION TO DISMISS BANKRUPTCY
• Young female investors’ pots ‘nearly £4,600 bigger than those belonging to men’
• Father of Modern Marketing Philip Kotler & ATLAS SkillTech University Professor Dr. Varsha Agarwal Co-Author B2B Brand Management Book